로딩 중…
지수 로딩 중…
Arcutis Biotherapeutics, Inc.
ARQT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$26.15-0.27%
2026-06-18
Price Chart
Arcutis Biotherapeutics, Inc.+91.29%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $3.27B |
| Revenue | $416M |
| Net Income | $-2M |
| Total Assets | $460M |
| Net Assets | $190M |
| Value | |
| P/B | 17.25x |
| P/S | 7.87x |
| EV/EBITDA | 254.39x |
| FCF Yield | 0.82% |
| Profitability | |
| ROE | -1.25% |
| ROA | -0.52% |
| Op. Margin | 0.77% |
| Revenue Growth | 60.07% |
| Financial Health | |
| Debt Ratio | 142.56% |
| Total Debt | $13M |
| FCF | $27M |
| Cash | $35M |
| Current Ratio | 2.68x |
| Net Debt/EBITDA | -1.69x |
| Performance | |
| 1Y Return | 91.29% |
| 1M Return | 34.10% |
| From 52W High | -17.69% |
| 1Y MDD | -37.50% |
| Trading | |
| Volume | 4,052,940 shares |
| Trading Value | $106M |
| Per Share | |
| EPS | $-0.13 |
| BPS | $1.48 |